首页> 美国卫生研究院文献>Eye >Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization

【2h】

Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization

机译：贝伐单抗或兰尼单抗作为玻璃体腔内抗血管内皮生长因子治疗的长期结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo evaluate the long-term efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy as primary treatment for subfoveal myopic choroidal neovascularization (CNV).

机译：目的评估玻璃体腔内抗血管内皮生长因子（anti-VEGF）治疗作为小凹下近视脉络膜新生血管（CNV）的主要治疗方法的长期疗效。

著录项

期刊名称 Eye
作者
T Y Y Lai; F O J Luk; G K Y Lee; D S C Lam;
展开▼
作者单位

展开▼
年(卷),期 2012(26),7
年度 2012
页码 1004–1011
总页数 8
原文格式 PDF
正文语种
中图分类眼科学;
关键词
ranibizumab bevacizumab anti-VEGF therapy choroidal neovascularization pathologic myopia high myopia;

机译：雷珠单抗;贝伐单抗;抗VEGF治疗;脉络膜新生血管;病理性近视;高度近视;

相似文献

外文文献
中文文献
专利

1. Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization [J] . LaiT.Y.Y., LukF.O.J., LeeG.K.Y., Eye . 2012,第7期

机译：贝伐单抗或兰尼单抗作为玻璃体腔内抗血管内皮生长因子疗法的长期结果，是治疗小凹下近视脉络膜新生血管的主要方法
2. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization [J] . Seong Joon Ahn, Kyu Hyung Park, Se Joon Woo Investigative ophthalmology & visual science . 2015,第10期

机译：近视脉络膜新生血管形成中抗血管内皮生长因子治疗后小凹脉络膜厚度的变化
3. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization [J] . Seong Joon Ahn, Kyu Hyung Park, Se Joon Woo Investigative ophthalmology & visual science . 2015,第10期

机译：近视脉络膜新生血管形成中抗血管内皮生长因子治疗后小凹脉络膜厚度的变化
4. Transpupillary thermotherapy for the treatment of choroidal neovascularization in age-related macular degeneration [C] . Chang-Hao Yang, Tzu-Hsun Tsai, Chung-May Yang, . 2004

机译：经瞳孔热疗法治疗年龄相关性黄斑变性的脉络膜新生血管
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization [O] . Devangna Bhatia, Alexander Mehta, Joanna DaCosta, 2021

机译：近视脉络膜新生血管中的现实世界抗血管内皮生长因子治疗结果
7. Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization [O] . T Y Y Lai, F O J Luk, G K Y Lee, 2012

机译：玻璃体内抗血管内皮生长因子治疗的长期结果用贝伐单抗或雷尼兹米亚布作为子宫近代脉络膜新生血管的主要疗法

Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization

摘要

著录项

相似文献

相关主题

期刊订阅